Ailanthus altissima Extract Ameliorates Cognitive Decline and Neurodegeneration in an Aluminum Chloride–Induced Rat Model of Alzheimer’s Disease
Authors:
- Mohammad Mehdi GravandiMGMohammad Mehdi Gravandi
- Daniel Elieh-Ali-KomiDEDaniel Elieh-Ali-Komi
- Roshanak AmirianRARoshanak Amirian
- Seyede Zahra HosseiniSHSeyede Zahra Hosseini
- Seyede Darya AlaviSASeyede Darya Alavi
- Samira ShirooieSSSamira Shirooie
- Amir KianiAKAmir Kiani
- Mohammad Hosein FarzaeiMFMohammad Hosein Farzaei
Open Access
- 1 January 2026
- journal article
- Published by Wiley in Journal of Food Biochemistry
- Vol. 2026 (1)
Abstract
Background: The extract of Ailanthus altissima possesses anti‐inflammatory and neuroprotective properties. We aimed to investigate its effectiveness in mitigating the AlCl 3 ‐induced Alzheimer’s disease in a rat model. Methods: A total of 32 adult male Wistar rats were divided into 4 groups each consisting of 8 rats. The control group received saline and the AlCl 3 group received AlCl 3 (0.2 cc 100 mg/kg, intraperitoneal) for 14 days. Two other groups received either 50 or 100 mg/kg of Ailanthus altissima after AlCl 3 treatment. Behavioral tests including open field test (OFT), elevated plus maze, and passive avoidance tests were performed. Nuclear factor kappa B (NF‐κB), glial filamentous acidic protein (GFAP), and amyloid beta were stained using immunohistochemistry (IHC) in the hippocampus. Results: AlCl 3 administration caused significant memory impairment, and treatment with Ailanthus altissima extract effectively mitigated these deficits in a dose‐dependent manner. The effects were dose‐dependent, and the group receiving 100 mg/kg extract presented the most significant results in the conducted behavioral tests. The IHC results for NF‐κB showed that treatment with 50 mg/kg of extract significantly reduced NF‐κB expression compared with the AlCl 3 group (6.64% vs. 13.3%, respectively, p < 0.05). A higher dose of 100 mg/kg resulted in an even greater reduction (4.45% vs. 13.3%, p < 0.01). Extract treatment reduced GFAP positivity in a dose‐dependent manner, with the 50 mg/kg group showing a significant decrease to 11.8% ( p < 0.05). The 100 mg/kg group demonstrated an even more substantial reduction to 7.7% ( p < 0.01) compared with the AlCl 3 group (18.65%). Amyloid beta positivity was critically reduced in the 100 mg/kg‐receiving group. Conclusions: Ailanthus altissima extract shows potential as a neuroprotective extract. It counteracts AlCl 3 ‐induced behavioral and neuropathological changes, suggesting promising therapeutic applications.Keywords
Funding Information
- Kermanshah University of Medical Sciences (4000918)
This publication has 33 references indexed in Scilit:
- The NF-κB pathway: Key players in neurocognitive functions and related disordersEuropean Journal of Pharmacology, 2024
- Isolation of four new monoterpenes from Ailanthus altissima (mill.) Swingle and their enzyme inhibitory effectsFitoterapia, 2024
- Protective effect of a hydromethanolic extract from Fraxinus excelsior L. bark against a rat model of aluminum chloride-induced Alzheimer's disease: Relevance to its anti-inflammatory and antioxidant effectsJournal of Ethnopharmacology, 2024
- Rutin-loaded chitosan nanoparticles alleviated Freund’s adjuvant induced rheumatoid arthritis via modulating oxidative stress and inflammatory parameters in Wistar ratsNaunyn-Schmiedeberg's Archives of Pharmacology, 2023
- Alzheimer’s disease: Insights and new prospects in disease pathophysiology, biomarkers and disease-modifying drugsBiochemical Pharmacology, 2023
- Traditional uses, phytochemistry, and pharmacology of Ailanthus altissima (Mill.) Swingle bark: A comprehensive reviewJournal of Ethnopharmacology, 2021
- Glial Fibrillary Acidic Protein in the Diagnosis and Prognosis of Malignant Glial TumorsBulletin of Experimental Biology and Medicine, 2020
- Neuro-inflammation and anti-inflammatory treatment options for Alzheimer's diseaseClinical Biochemistry, 2019
- Neuroprotective Effect of Nanodiamond in Alzheimer’s Disease Rat Model: a Pivotal Role for Modulating NF-κB and STAT3 SignalingMolecular Neurobiology, 2016
- Costimulatory Effects of Interferon-γ and Interleukin-1β or Tumor Necrosis Factor α on the Synthesis of Aβ1-40 and Aβ1-42 by Human AstrocytesNeurobiology of Disease, 2000